SCHEMBL3121602

SCHEMBL3121602

CC(C=O)N1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3132292 0.97 FDPS (0.36)
Hydrochloric Acid SCHEMBL11682972 0.95 FDPS (0.34)
SCHEMBL18724534 0.94
SCHEMBL18724744 0.79 MC4R (0.38)
SCHEMBL36573 0.77 MAPT (0.39)
SCHEMBL10760912 0.77 FDPS (0.40)
SCHEMBL1819138 0.77 CHRM2 (0.34)
SCHEMBL18724677 0.75 ALDH1A1 (0.39)
SCHEMBL29771945 0.75
SCHEMBL27737518 0.74 SIGMAR1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250002464-A1 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME SAPIENSBIO INC. (KR) 2025-01-02 US claimed
EP-4421070-A1 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME Sapiensbio Inc. (KR) 2024-08-28 EP claimed
CN-118119612-A Novel compounds and pharmaceutical compositions comprising the same 萨皮恩斯生物有限公司 2024-05-31 CN claimed
WO-2023068755-A1 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 사피엔스바이오 2023-04-27 WO claimed
EP-1487806-B1 4-ANILINO QUINAZOLINE DERIVATIVES AS ANTIPROLIFERATIVE AGENTS ASTRAZENECA AB (SE) 2010-07-07 EP claimed
US-20250002464-A1 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME SAPIENSBIO INC. (KR) 2025-01-02 US disclosed
EP-4421070-A1 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME Sapiensbio Inc. (KR) 2024-08-28 EP disclosed
CN-118119612-A Novel compounds and pharmaceutical compositions comprising the same 萨皮恩斯生物有限公司 2024-05-31 CN disclosed
CN-102822171-B As the benzo naphthyridines amine of autotaxin inhibitors MERCK PATENT GMBH (DE) 2015-09-02 CN disclosed
CN-102595893-B Spirolactam derivatives and uses of same LUNDBECK & CO AS H 2014-12-31 CN disclosed
CN-101611005-B Substituted acetophenones useful as PDE4 inhibitors LEO PHARMA AS 2013-11-06 CN disclosed
US-8399667-B2 4-anilino quinazoline derivatives as antiproliferative agents ASTRAZENECA AB (GB) 2013-03-19 US disclosed
US-5245052-A PROCESS FOR PRODUCING 6-ACYL-7-DEACETYLFORSKOLIN DERIVATIVES NIPPON KAYAKU CO. LTD. (JP) 1993-09-14 US disclosed
CN-1016869-B Process for preparing 6, 7-diacyl-7-deacetylforskolin derivatives NIPPON KAYAKU KK (JP) 1992-06-03 CN disclosed
CN-1060291-A The novel method of preparation 6-acyl group-7-deacetylforskolin derivatives HOECHST JAPAN (JP) 1992-04-15 CN disclosed
EP-0469428-A1 Novel process for producing 6-acyl-7-deacetylforskolin derivatives HOECHST JAPAN LIMITED (JP) 1992-02-05 EP disclosed
CN-1030583-A Preparation 6,7-diacyl-7-takes off the novel method of acetyl forskrine derivant NIPPON KAYAKU KK (JP) 1989-01-25 CN disclosed
EP-0297496-A2 Novel process for the preparation of 6,7-Diacyl-7-deacetylforskolin derivatives NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1989-01-04 EP disclosed
EP-0236140-A2 Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1987-09-09 EP disclosed
US-4093812-A MICROBIOCIDES, DISINFECTANTS BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DT) 1978-06-06 US disclosed